Endoscopy in inflammatory bowel disease

Minerva Gastroenterologica e Dietologica

Volumn 59, Issue 3, 2013, Pages 273-284

  Carter, D ^a   Lang, A ^a   Eliakim, R ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Capsule endoscopy; Colitis, ulcerative; Crohn disease; Intestine, small

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

CANCER EPIDEMIOLOGY; CANCER PROGNOSIS; CAPSULE ENDOSCOPY; CHROMOENDOSCOPY; CLINICAL PRACTICE; COLON RESECTION; COLONOSCOPY; CROHN DISEASE; DEVICE ASSISTED ENTEROSCOPY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; FOLLOW UP; GASTROINTESTINAL TRACT; HEALING; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; INTESTINE MUCOSA; INTESTINE PERFORATION; INTESTINE ULCER; PANCOLITIS; POLYPECTOMY; PREDICTIVE VALUE; REVIEW; TOXIC MEGACOLON; ULCERATIVE COLITIS;

ENDOSCOPY, GASTROINTESTINAL; HUMANS; INFLAMMATORY BOWEL DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 84885033786     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. American Society for Gastrointestinal Endoscopy guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006;63:558-65.
2. Carbonnel F, Lavergne A, Lemann M, Biton A, Valleur P, Hautefeuille P et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994;39:1550-7. (Pubitemid 24246449)
3. Navaneethan U, Parasa S, Venkatesh PG, Trikudanathan G, Shen B. Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients. J Crohns Colitis 2011;5:189-95.
4. Bernstein C, Shanahan F, Anton P, Weinstein WM. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc 1995;42:232-7.
5. Cornaggia M, Leutner M, Mescoli C, Sturniolo GC, Gullotta R. Chronic idiopathic inflammatory bowel diseases: the histology report. Dig Liver Dis 2011;43:S293-303.
6. Rao KV, Sterling MJ, Klein KM. Isolated gastroduodenal Crohn's disease presenting with acute pancreatitis. Gastroenterol Hepatol 2008;4:494-9.
7. Mehdizadeh S, Chen GC, Barkodar L, Enayati PJ, Pirouz S, Yadegari M et al. Capsule endoscopy in patients with Crohn's disease::diagnostic yield and safety. Gastrointest Endosc 2010;71:121-7.
8. Molinie F, Gower-Rousseau C, Yzet T, Merie V, Grandbastien B, Marti R et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004;53:843-8. (Pubitemid 38662134)
9. Bourreille A, Ignjatovic A, Aabakken L, Loftus EV Jr, Eliakim R, Pennazio M et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009;41:618-37.
10. Haskell H, Andrews CW Jr., Reddy SI, Dendrinos K, Farraye FA, Stucchi AF,et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Path 2005;29:1472-81. (Pubitemid 41513297)
11. Leighton JA. The role of endoscopic imaging of the small bowel in clinical practice. Am J Gastroenterol 2011;106:27-36.
12. Kornbluth A, Colombel JF, Leighton JA, Loftus E. ICCE consensus for inflammatory bowel disease. Endoscopy 2005;37:1051-4. (Pubitemid 41489287)
13. Koulaouzidis A, Douglas S, Rogers MA, Arnott ID, Plevis JN. Fecal calprotectin:a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy. Scand J Gastroenterol 2011;46:561-6.
14. Adler SN, Yoav M, Eitan S, Yehuda C, Eliakim R. Does capsule endoscopy have an added value in patients with perianal disease and a negative work up for Crohn's disease? World J Gastrointest Endosc 2012;4:185-8.
15. Li F, Gurudu SR, De PG, Sharma VK, Shiff AD, Heigh RI et al. Retention of the capsule endoscope:a single-center experience of 1000 capsule endoscopy procedures. Gastrointest Endosc 2008;68:174-80.
16. Sachdev MS, Leighton JA, Fleischer DE, Heigh RI, Hara AK, Post JA et al. A prospective study of the utility of abdominal radiographs after capsule endoscopy for the diagnosis of capsule retention. Gastrointest Endosc 2007;66:894-900. (Pubitemid 47610774)
17. Postgate A, Despott E, Burling D, Gupta A, Phillips R, O'Beirne J et al. Significant small-bowel lesions detected by alternative diagnostic modalities after negative capsule endoscopy. Gastrointest Endosc 2008;68:1209-14.
18. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicenter study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut1989;30:983-9.
19. Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne JF et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicenter study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994;35:231-5. (Pubitemid 24092870)
20. Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505-12. (Pubitemid 39311530)
21. Baert F, Moortgat L, Van Assche G, Caenepeel P, Verqauwe P, De Vos M et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010;138:463-8.
22. Kato J, Kuriyama M, Hiraoka S, Yamamoto K. Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitispatients? J Gastroenterol Hepatol 2011;26:683-7.
23. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F et al. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987;92:1894-8. (Pubitemid 17072238)
24. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized control trial. Br Med J 1989;298:82-6. (Pubitemid 19032930)
25. Schroeder KW, Tremaine W, Ilstrup DM. Coasted oral 5-aminosalycylic acid therapy for mildly to moderately active ulcerative colitis. New Engl J Med 1987;317:1625-9. (Pubitemid 18010466)
26. Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982;27:533-7. (Pubitemid 12120288)
27. Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the ulcerative colitis Endoscopic Index of Severity (UCEIS). Gut 2012;61:535-42.
28. Kiesslich R, Fritsch J, Holtmann M, Koehler H, Stolte M, Kanzler S et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8. (Pubitemid 36389789)
29. Gheorghe C, Cotruta B, Iacob R, Becheanu G, Dumbrava M, Gheorghe L. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis. Gastrointestin Liver Dis 2011;20:423-6.
30. Watanabe O, Ando T, Maeda O, Hasegawa M, Ishikawa D, Ishiguro K et al. Confocal endomicroscopy in patients with UC. J Gastroenterol Hepatol 2008;23 (Suppl 2):S286-290-290.
31. Rutgeerts P, Vermeire S, Van Assche G. What is the role of endoscopy in predicting Crohn's disease relapse or course? Inflamm Bowel Dis 2008;14(Suppl 2):S183-S184.
32. Frøslie KF, Jahnsen J, Mourn BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412-22. (Pubitemid 47187355)
33. Colombel JF, Sandborn WJ, Reinisch W, Mantazaris GJ, Kornbluth A, Rachmilewitz D et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-95.
34. Mantazaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K et al. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent CD. Inflamm Bowel Dis 2009;15:375-82.
35. Lémann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E et al. A randomized, double-blind, controlled withdrawal trial in Crohn's diseasepatients in long-term remission on azathioprine. Gastroenterology 2005;128:1812-8. (Pubitemid 40824692)
36. D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomized trial. Lancet 2008;371:660-7. (Pubitemid 351284485)
37. Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi et al. Randomized controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55:47-53. (Pubitemid 41820634)
38. Ferrante M, Vermeire S, Fidder H, Schnitzler F, Noman M, Van Assche G et al. Long-term outcome after infliximab for refractory ulcerative colitis. J Crohns colitis 2008;2:219-25.
39. Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology 2009;137:1250-60.
40. Allez M, Lémann M. Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol 2010;16:2626-32.
41. Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010;16:338-46.
42. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76. (Pubitemid 41770166)
43. Rosa B, Moreira MJ, Rebelo A, Cotter J. Lewis Score:a useful clinical tool for patients with suspected Crohn's Disease submitted to capsule endoscopy. J Crohns Colitis.2012;6:692-7.
44. Niv Y, Ilani S, Levi Z, Hershkowitz M, Niv E, Fireman Z et al. Validation of the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score):a multicenter prospective study. Endoscopy 2012;44:21-6.
45. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984;25:665-72. (Pubitemid 14122134)
46. Rutgeerts P, Geboes K, Vantrappen G, Beyls J,Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63. (Pubitemid 20338451)
47. Mehdizadeh S, Chen GC, Barkodar L, Enayati PJ, Pirouz S, Yadegari M et al. Capsule endoscopy in patients with Crohn's disease: diagnostic yield and safety. Gastrointest Endosc 2010;71:121-7.
48. Long MD, Barnes E, Isaacs K, Morgan D, Herfarth HH. Impact of capsule endoscopy on management of inflammatory bowel disease:a single tertiary care center experience. Inflamm Bowel Dis 2011;17:1855-62.
49. Leighton JA, Legnani P, Seidman EG. Role of capsule endoscopy in inflammatory bowel disease: where we are and where are we going. Inflamm Bowel Dis 2007;13:331-7. (Pubitemid 46465915)
50. Shen B, Achkar JP, B. Lashner BA, Ormsby AH, Remzi FH, Brzezinski A et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001;121:261-7. (Pubitemid 32729373)
51. Shen B, Lashner BA, Bennet AE, Remzi FH, Brzezinski A, Achkar JP et al. Treatment of rectal inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch anal anastomosis. Am J Gastroenterol 2004;99:1527-31. (Pubitemid 39180102)
52. Winther KV, Jess T, Langholz E, Munkholm P, Binder V. Long-term risk of cancer in study from Copenhagen County. Clin Gastroenterol Hepatol 2004;2:1088-95.
53. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA et al. Analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-88.
54. Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S et al. Risk factors for ulcerative colitis - associated colorectal cancer in a Hungarian cohort of patients with UC:results of a population-based study. Inflamm Bowel Dis 2006;12:205-11.
55. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis:a meta-analysis. Gut 2001;48:526-35. (Pubitemid 32234798)
56. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981;48:2742-5. (Pubitemid 12194270)
57. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;53(suppl 5):V1-16.
58. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:746-74.
59. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schonfield G, Kamm M et al. Severity of inflammation is a risk factor for neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9. (Pubitemid 38182302)
60. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterol 2004;126:1634-48. (Pubitemid 38649879)
61. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000;51:123-8. (Pubitemid 30094501)
62. Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H:Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996;44:8-14. (Pubitemid 26268652)
63. Dekker E, van den Broek FJ, Reitsma JB, Hardwick JC, Offerhaus GJ, van Deventer SJ et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with long-standing ulcerative colitis. Endoscopy 2007;39:216-21. (Pubitemid 46510792)
64. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366-74. (Pubitemid 11217532)
65. Rubin PH, Firedman S, Harpaz N, Goldstein E, Weiser J, Schiller J et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999;117:1295-300.
66. Goldberg HI, Caruthers SB Jr, Nelson JA, Singleton JW. Radiographic findings of the National Cooperative Crohn's Disease study. Gastroenterology 1979;77:925-37. (Pubitemid 9242055)
67. Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938-41.
68. Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH, Greenstein JR. Malignant colorectal strictures in Crohn's disease. Am J Gastroenterol 1991;86:882-5.
69. Wibmer AG, Kroesen AJ, Grone J, Buhr HJ, Ritz JP. Comparison of strictureplasty and balloon dilatation for structuring Crohn's disease-review of the literature. Int J Colorectal Dis 2010;25:1149-57.
70. Hassan C, Zullo A, De Francesco V, Lerardi E, Giusti M, Pitidis A et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007;26:1457-64. (Pubitemid 350178804)
71. Erkelens GW, van Deventeer SJH. Endoscopic treatment of strictures in Crohn's disease. Best Pract Res Clin Gastroenterol 2004;18:201-7. (Pubitemid 38181621)
72. Grubel P, Choi Y, Schneider D, knox TA, Cave DR. Severe isolated Crohn's-like disease of the gastroduodenal tract. Dig Dis Sci 2003;48:1360-5. (Pubitemid 36793916)